We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Clinical sites facing an inspection at the request of the Committee for Medicinal Products for Human Use must sign a letter consenting to the audit and promising to provide all relevant documents, a European Medicines Agency guideline on GCP inspection procedures says. Read More
Clinical research staff working on corrective and preventive action reports should think seriously about the root causes of good clinical practice violations identified at their sites and how to prevent those errors from recurring. Read More
The number of clinical trials in India is rebounding after plunging precipitously in the wake of strict government regulations imposed on the industry. Read More
Sponsors designing clinical trials that involve certain vulnerable patient populations will soon face greater scrutiny from institutional review boards, under newly issued FDA guidance. Read More
Sponsors designing clinical trials that involve certain vulnerable patient populations will soon face greater scrutiny from institutional review boards, under newly issued FDA guidance. Read More
Multiple lapses in informed consent and institutional review board procedures landed an FDA warning letter for clinical trial sponsor Rogerio Lobo, a physician in the Department of Obstetrics and Gynecology at Columbia University Medical Center in New York City. Read More
A Georgia clinical investigator was warned by the FDA for failing to properly randomize and dose patients participating in a GlaxoSmithKline study evaluating albiglutide in patients with type 2 diabetes. Read More
Sponsors in India are calling for the government to settle a prolonged lawsuit over clinical trial deaths, a move experts say could revive trial activity in the country. Read More
Investigators participating in clinical trials in India must limit their work to no more than three trials at any given time. That’s one of mandates laid out in 14 finalized regulations issued July 3 by the Central Drugs Standard Control Organization. Read More
The FDA is reaching out to sponsors of trials of therapies for neglected tropical diseases with new final guidance that encourages them to seek accelerated approval pathways, such as breakthrough therapy designation and qualified infectious disease product status. Read More
A trade group of leading Indian drug companies is pushing the government to settle a prolonged lawsuit over clinical trial deaths; a move that two industry consulting groups are hopeful will revive sluggish clinical trial activity in the country. Read More